By Joseph Burns, from the Volume XXIV, No. 15 – October 30, 2017 issue
CEO SUMMARY: In the past year, both national laboratory companies have increased the number of patient service centers they operate in retail pharmacies and grocery stores. But these PSCs are not serving direct access testing (DAT) customers. Rather, early evidence indicates that patients are finding it more convenient to go to their nearby grocery stores
By Joseph Burns, from the Volume XXII NO. 11 - August 3, 2015 issue
CEO SUMMARY: For clinical laboratories and anatomic pathology groups willing to adapt to the evolving needs of the American healthcare system, there are many positive opportunities. That’s the view of a Wall Street investment bank that just published a report on the lab testing sector. The report on healthcare trends includes commentary about developments in cancer care, acceptance of personalized medicine, and the growing activity in direct-to-consumer lab testing.
By Robert Michel, from the Volume XVII No 14 - October 4, 2010 issue
CEO SUMMARY: Ask most pathologists and laboratory administrators about the FDA’s intent to regulate laboratory-developed tests (LDTs), and they will likely answer that it is to control web-based direct-to-consumer lab testing companies and the rapidly- growing number of proprietary tests. Although that is true, any move to regulate LDTs also has the potential to cover
By Robert Michel, from the Volume XIII No. 10 - July 24, 2006 issue
There’s a new crop of Web- based, direct-to-consumer laboratory companies. In recent months, Joplin-Missouri-based MyMedLab, Inc., (www. mymedlab.com) and Med-LabUSA, LLC of Tampa Florida ( www.medlabusa.com) have begun to seek publicity. Both companies offer patients a way to order laboratory tests directly via the Internet and both companies contract with other laboratories to perform the
